A Study to Assess the BioTraceIO System for Identifying Tissue Damage from Microwave Thermal Liver Ablation


About this study

The purpose of this study is to evaluate the accuracy of the BioTrace IO during RFA/MWA Transcutaneous procedures.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Cases with single ablation per tumor.
  • Cases with more than 1 ablation per patient only if the distance between the tumors is at least 8 cm.

Exclusion Criteria:

  • Cases with tumor size larger than 4 cm.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Sadeer Alzubaidi, M.D.

Closed for enrollment

Contact information:

Teresa Sniezek B.S.

(480) 342-0349


More information


Publications are currently not available